The Bill & Melinda Gates Foundation has pledged $2.5 billion over the next six years to transform women’s health outcomes worldwide, targeting systemic underfunding in research for conditions that disproportionately affect women in low- and middle-income countries. Announced on June 4, the initiative aims to accelerate breakthroughs in maternal care, menstrual and gynecological health, contraception, and sexually transmitted infection (STI) management through more than 40 innovations.
Despite women making up half the global population, a 2021 McKinsey & Company analysis found only 1% of healthcare research funding addresses female-specific conditions outside cancer. This neglect leaves critical issues like preeclampsia, endometriosis, and postpartum hemorrhage—conditions impacting hundreds of millions—without adequate diagnostic tools or treatments. “Women’s health has been sidelined for generations,” said Dr. Anita Zaidi, president of the foundation’s Gender Equality Division. “This is about prioritizing their lives, bodies, and voices in scientific innovation.”
The funding will focus on five areas identified through data and direct input from women in underserved regions: improving pregnancy safety through obstetric care and maternal immunization; enhancing nutrition for healthier pregnancies; advancing gynecological and menstrual health tools; expanding contraceptive options; and improving STI diagnosis and treatment. Early-stage projects include pioneering research into the vaginal microbiome, non-hormonal birth control, and therapies for preeclampsia, a leading cause of maternal death.
Bill Gates emphasized the broader societal impact: “Investing in women’s health strengthens families, economies, and global equity.” Studies suggest every dollar directed toward closing the gender health gap could generate $3 in economic growth, with potential to add $1 trillion annually to the global economy by 2040.
The foundation called for collaboration from governments, investors, and pharmaceutical companies to scale solutions. Dr. Bosede Afolabi, a Nigerian obstetrician, noted the urgency: “Women in resource-limited settings face preventable suffering and death daily due to gaps in research. This commitment must catalyze wider action.”
The initiative aligns with the foundation’s 2045 goals to end preventable maternal and infant deaths, combat infectious diseases, and reduce poverty. It builds on decades of work in maternal and child health, including HPV vaccine distribution and prenatal care programs. While the pledge marks the organization’s largest single investment in women’s health, officials stressed that sustained global cooperation is essential to address a crisis long overlooked by mainstream research agendas.
